ENDPOINTS

Altos Labs buys anti-aging startup Dorian Therapeutics

Altos Labs, the massive but still relatively secretive $3 billion biotech, has forged a small acquisition of a startup seeking to reverse aging. Altos, led by industry stalwarts Hal Barron and Hans ...

May 21, 2025 - 09:34
 0
Altos Labs buys anti-aging startup Dorian Therapeutics
Altos Labs, the massive but still relatively secretive $3 billion biotech, has forged a small acquisition of a startup seeking to reverse aging. Altos, led by industry stalwarts Hal Barron and Hans ...
Read More

Tags:

Previous Article

Reproductive health biotech ReproNovo closes $65M Series A

Next Article

Jumbo task: 400 pills a day for elephants with TB in Pakistan

Related Posts

HHS issues guidance for third round of drug price negotiations

HHS issues guidance for third round of drug price negot...

May 13, 2025  0

BioMarin makes Phase 3 buy, paying $270M for rare disease outfit Inozyme

BioMarin makes Phase 3 buy, paying $270M for rare disea...

May 16, 2025  0

Novo Nordisk’s global obesity leader is moving on; Flagship biotech gets CEO from Scholar Rock

Novo Nordisk’s global obesity leader is moving on; Flag...

May 16, 2025  0